Menopause Market

Market Overview

The menopause market is growing significantly. Market expansion is anticipated as a result of a growing incidence of postmenopausal symptoms brought on by a change to a sedentary life. The aging population, growing awareness, technology improvements, and rising healthcare costs are some of the key factors driving the menopausal and post-menopause industry and creating need for novel and creative solutions. As women become more knowledgeable about menopause and its symptoms, more of them are looking for treatment alternatives. The number of women going through menopause is predicted to rise in the upcoming years due to the global aging population. Menopause medications have a big market opportunity because of this.

Women are experiencing more menopausal symptoms due to changes in life and sedentary habits. These symptoms include hot flashes, irregular mood swings, and sleeplessness. Menopause medications that help lessen these symptoms are in greater demand as a result of this. New therapeutic options have become available as a result of increased menopausal research and development. The potential advantages of novel medicines, such bioidentical hormones and low-dose antidepressants, are being investigated. Women now have many alternatives for managing their symptoms because to the growing popularity of alternative therapies and natural cures. Menopause management and knowledge will improve much more as a result of the continuous research and innovation.

Menopause Market Size

Report	Details
Market Size Value	USD 16.93 Billion in 2023
Market Size Value	USD 25.42 Billion by 2030
CAGR	5.37 %
Forecast Period	2023-2030
Base Year	2023
Historic Data	2020

Major vendors in the global menopause market are Theramex, Rainbow Light, Pure Encapsulations, LLC., PADAGIS LLC, Dr. Reddy’s Laboratories Ltd., Bayer AG, AbbVie Inc., and Abbott., TherapeuticsMD, Teva Pharmaceuticals Limited, Novo Nordisk, Cipla Inc., Eli Lily, Emcure, Glenmark Pharmaceuticals Limited, Merck, Novartis, and Others.

Growth in Focus on Women's Health

Women's health, particularly during menopause, has traditionally not received the same level of attention as men's health. However, a significant driver of the menopause market is the increasing prioritization of women's health in general. Historically, research and development have been focused on conditions that affect men, resulting in a knowledge gap regarding women's health issues. Menopause, being a natural stage of life, has often been surrounded by secrecy and had limited available solutions. The growing acknowledgment of the importance of women's health is leading to more significant investments, research, and awareness campaigns. This shift is creating a more welcoming environment for products and services related to menopause. Statistical data reinforces this change. A report from McKinsey & Company in 2022 highlights a surge in investments in women's health startups, with venture capital funding tripling since 2018. The global women's health market is expected to reach a remarkable USD 1 trillion by 2025. This increased focus on women's health not only benefits the menopause market but also empowers women to have a healthier and more comfortable menopause journey.

Market Dynamics

Drivers:

• vasomotor and other menopausal symptoms are prevalent
• Rise in the awareness of menopause health
• Growing number of newly approved drugs for the purpose of treating
• Growth in Focus on Women's Health
• availability of diversified treatment options
• Rise in the aging population

Opportunities:

• Prevalence of herbal treatment for menopause
• Increase in the research of the dietary supplements
• Innovation in product and service
• Development of Targeted Therapies      

Innovation in product and service

The menopause market shows a plethora of inventive product and service potential. Women used to only have access to Hormone Therapy (HT) and a narrow range of over-the-counter medicines, but these days they want more alternatives. Here's where creativity comes into its own. The market may increase the variety of treatment options available by launching innovative Non-Hormonal Therapies (NHT) that are backed by strong scientific evidence. This expansion might include customized drugs, well-researched natural supplements, and creative delivery systems. The creation of combination solutions that address several illnesses, intelligent gadgets that track symptoms and give customized recommendations, and subscription services that make customized decisions depending on user needs are all examples of how innovation may improve personalized care. In the end, women can be empowered by innovations in products and services that offer more effective, customized, and practical ways for them to manage the menopausal transition.

The market for Menopause is dominated by North America.

In 2023, North America is the largest stockholder in the menopausal market globally. The region's market is anticipated to develop as a result of an increasing focus on customized medicine, early diagnosis and treatment, and the quick uptake of healthcare applications for online consultations of over-the-counter (OTC) medications. The market will be further stimulated by growing regulatory backing and investments in menopausal medicines. For instance, financing has been provided to the Silicon Valley business "Your Menopause Microbiome" in order to develop a customized online platform that suggests over-the-counter items for women. Given that women in the area have high levels of internet literacy and access to modern technology, it is expected that these firms would raise demand for over-the-counter pharmaceuticals that reduce menopausal symptoms like hot flashes. North America has a highly developed and controlled pharmaceutical sector. Furthermore, it is projected that the existence of groups like the North American menopausal Society, which promotes menopausal awareness, will fuel market expansion in North America.

Europe is expected to exhibit a highest CAGR over the forecast period. Many women in the area go through menopause each year, and menopausal symptoms including vaginal dryness are quite prevalent in this area. In 2018, the National Cancer Institute (NCBI) reported that early menopause is being caused by women's increased obesity prevalence. In the area, between 10% and 30% of women are obese. Furthermore, the intensity of menopausal symptoms like hot flashes and sweats increased with an obese woman's body mass index. As a result, a rise in the demand for menopausal therapies is anticipated. To alleviate menopausal symptoms, Bayer AG, Reckitt Benckiser Group, and GlaxoSmithKline plc distribute vaginal lubricants and moisturizers in this area. Moreover, it is projected that the availability of improved healthcare services will propel the market over the projected time. As prominent players in the industry launch new goods, doctors suggest dietary supplements as a healthy substitute for hormone replacement therapy (HRT) to help women transition through menopause more easily.

The Non-Hormonal Therapy type segment is anticipated to hold the largest market share during the forecast period

Based on therapy, the menopause market is divided into non-hormonal therapy and hormone replacement therapy HRT, which involves the administration of hormones to compensate for their reduced production during menopause, has been a go-to treatment for symptoms including mood swings, nocturnal sweats, and hot flashes. This segment's dominance is due to the fact that HRT is widely accepted by healthcare practitioners and is successful in reducing these symptoms. As women seek alternatives to manage symptoms without altering hormone levels. The menopause market is experiencing a significant shift towards non-hormonal therapy (NHT). The resulting non-hormonal therapy segment is expected to expand at a significant growth rate in the coming years, as it includes life modifications, herbal supplements, and non-hormonal medications. It is a safer and more natural alternative to HRT, with rising awareness about the benefits of a healthy life and the growing availability of non-hormonal treatments.

On the basis of an individual's needs, options are available. For instance, low-dose antidepressants like Fluoxetine (Prozac) effectively manage hot flashes, which is a common symptom that affects up to 75% of menopausal women. Similarly, gabapentin, which is typically used for nerve pain and reduces hot flash frequency, 

Segmentations Analysis of menopause market: -

• By Type:
  • Dietary Supplements
  • OTC Pharma Products
  • Hormonal Therapy
  • Non-Hormonal Therapy
  • Anti-Depressants
• By Clinical Practice:
  • Retail Pharmacies
  • Institutional Sales
  • Online Pharmacies
  • Hospital Pharmacies
  • Other
• By Stage:
  • Perimenopause
  • Menopause
  • Post-menopause
  • Others
• By Route of Administration:
  • Topical
  • Oral
  • Injectables
• By Drug:
  • Estrogen
  • Combination Drugs
  • Progestogen
  • SSRI
  • SNRI
  • Gabapentin
  • Others
• By End-Use:
  • Hospitals
  • Clinics
  • Home Care
  • Others
• By Region
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of Latin America
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • U.K.
    • BENELUX
    • CIS & Russia
    • Nordics
    • Austria
    • Poland
    • Rest of Europe
  • Asia Pacific

• • China
  • Japan
  • South Korea
  • India
  • Thailand
  • Indonesia
  • Malaysia
  • Vietnam
  • Australia & New Zealand
  • Rest of Asia Pacific

• • Middle East & Africa

• • Saudi Arabia
  • UAE
  • South Africa
  • Nigeria
  • Egypt
  • Israel
  • Turkey
  • Rest of MEA

 Recent Developments

• In June 2023, Upliv were launched by Aegis Ventures and Northwell Holdings which is a new virtual menopause care startup. Individual care and telemedicine services for employees going through menopause or perimenopause are offered by Upliv in collaboration with employers.
• In May 2023, the U.S. Food and Drug Administration approved Veozah (fezolinetant), an oral medication for the treatment of moderate to severe vasomotor symptoms, or hot flashes, caused by menopause. It provides an additional safe and effective treatment option for women.”
• In January 2023, the first-ever menopause gummy vitamin was introduced by the women's health company O Positiv, giving menopausal women a delightful and practical solution to control their symptoms.
• In January 2022, Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market operating platform announces that it has agreed to exclusive terms to acquire the assets of MenoLabs, LLC, a women-founded company to treat menopause symptoms, drive research for women's health and improve society's understanding of menopause.

Answers to Following Key Questions:

• What will be the menopause market’s Trends & growth rate? What analysis has been done of the prices, sales, and volume of the top producers in the menopause market?
• What are the main forces behind worldwide menopause market? Which companies dominate menopause market?
• Which companies dominate menopause market? Which business possibilities, dangers, and tactics did they embrace in the market?
• What are the global Insight Engines industry's suppliers' opportunities and dangers in menopause market?
• What is the Insight Engines industry's regional sales, income, and pricing analysis? In the menopause market, who are the distributors, traders, and resellers?
• What are the main geographic areas for various trades that are anticipated to have astounding expansion over the menopause market?
• What are the main geographical areas for various industries that are anticipated to observe astounding expansion for menopause market?
• What are the dominant revenue-generating regions for menopause market, as well as regional growth trends?
• By the end of the forecast period, what will the market size and growth rate be?
• What are the main menopause market trends that are influencing the market's expansion?
• Which key product categories dominate menopause market? What is menopause market’s main applications?
• In the coming years, which menopause market technology will dominate the market?